SEC FORM 4
$543,956.97
CORCEPT THERAPEUTICS INC (CORT)
Sale of 4,770 shares at $114.0371 per share.
Reporting Person Guyer William · Officer Title Chief Development Officer · Transaction Code S
Traded Aug 10, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001193125-26-346942 · filed 2026-08-12 · View filing →